Advances in Pediatric Food Allergy: Translating Evidence into Everyday Practice

Friday, May 1, 2026, 7:30 AM - 6:00 PM, Hess Center for Science and Medicine, Davis Auditorium, New York, NY


Through expert-led plenary sessions and interactive workshops, this course translates emerging research into practice-changing strategies. Key topics this year include anaphylaxis management, immunotherapy, prevention, and the psychosocial impact of food allergies. Participants will leave equipped with actionable strategies to improve patient care and quality of life.

1. Integrate emerging evidence into the management of various food allergy phenotypes.
2. Apply updated oral food challenge protocols to accurately diagnose food allergies and assess reaction thresholds.
3. Develop and implement home anaphylaxis action plans in partnership with patients and caregivers to reduce delays in epinephrine administration.
4. Improve growth and nutritional status outcomes in children with food allergy through interdisciplinary care.
5. Enhance quality of life for patients and their families by integrating psychosocial assessment and targeted support into routine clinical practice.
6. Increase successful desensitization and sustained unresponsiveness rates through appropriate patient selection and protocol optimization in immunotherapy programs.
7. Implement evidence-based prevention strategies in high-risk populations.

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (5.75 hours), Non-Physician Attendance (5.75 hours)

You are not logged in.

Please click the button below to login or create a new account before continuing.

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all accredited CE educational activities. All individuals in control of content of an activity accredited by ISMMS are expected to disclose all their financial relationships with ineligible companies existing within the prior 24 months. All relevant financial relationships have been mitigated and disclosed to learners before the activity takes place. 

Friday, May 1, 2026